Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study

Abstract Background: The use of anticoagulant bridging remains controversial. This study was conducted to evaluate our warfarin periprocedural management in Qatar and investigate the associated clinical outcomes with such management. Methods: A prospective cohort designed describe practice patients compare safety efficacy between nonbridging. Results: 103 were recruited. Bridging occurred 82% participants. No thromboembolic events observed, while 39.1% experienced bleeding during period. incidence overall major numerically higher for group compared nonbridging but did not reach statistical significance ([30.6% vs 22.2%, P?=?0.478] [12.9% 5.6%, P?=?0.375], respectively). Conclusion: Warfarin interruption are overwhelmingly used warfarin-treated Qatar. While increased events, there is no difference reported strategies.